Sponsors

Indica Labs and Lunit announce alliance for digital pathology

Digital pathology and image management firm Indica Labs, and Lunit, a leading medical AI software platform company focused on cancer biomarkers have announced an agreement to provide a fully interoperable solution between Indica Labs’ HALO AP image management software platform and Lunit’s suite of AI pathology products.

"Leveraging the power of digital pathology and artificial intelligence to improve tissue-based research and patient care is at the core of our mission," said Steven Hashagen, founder and CEO of Indica Labs. "This valued collaboration enables us to seamlessly integrate Lunit’s AI pathology solutions, including Lunit SCOPE PD-L1 for non-small cell lung cancer (NSCLC) into HALO AP, our CE-IVD certified clinical image management platform."

The combined solution is already in use at Guardant Health, a leading precision oncology company.

Brandon Suh, CEO of Lunit said, "The partnership with Indica Labs, a market leader in digital pathology, with interoperable workflow integration, will enable pathologists and labs to deliver faster, more accurate, and more reproducible answers using Lunit’s AI solutions."

Lunit SCOPE PD-L1 NSCLC is a CE-marked AI solution for detecting and analysing PD-L1 TPS, a cancer biomarker. The solution may assist pathologists by minimising interpretation variability and allowing better prediction of treatment outcomes for NSCLC patients, as demonstrated in study findings published in the European Journal of Cancer.

Pictured above is an example of the Lunit SCOPE PD-L1 NSCLC markup image in HALO AP. The cyan, blue and orange masks reflect the local tumour proportion score (TPS). Positive cells are shown in purple while negative cells are shown in cyan.

Indica Labs developed the HALO AP platform specifically to meet the needs of anatomic pathology laboratories worldwide. The CE-IVD certified HALO AP platform supports a wide range of tissue-based workflows, including primary diagnosis, secondary consults, clinical trials, synoptic reporting, quantitative analytics and AI. One of the key advantages of HALO AP is the seamless integration of AI solutions into the workflow, whether developed by Indica Labs or third parties. To simplify integration, a HALO AP software development kit (SDK) is available to all algorithm developers. With HALO AP, users can utilise algorithms in an automated, stepwise workflow that can be locked, secured and audited to prevent tampering or misuse.

 

Latest Issues

DIA-MHRA Global Summit

Senate House, Malet Street, London, WC1E 7HU
16-17 November, 2026

UK NEQAS for Microbiology & Parasitology Annual Scientific Meeting 2026

The Royal National Hotel, 38 – 51 Bedford Way, London, WC1H 0DG
27 November, 2026

UK NEQAS webinar: Epigenetics

Online
1 December, 2026

Weqas Annual POCT Conference 2026

London, Venue - TBC
8-9 December, 2026

UK NEQAS webinar: Fresh Muscle Biopsies

Online
8 December, 2026